Genomic characterisation and risk stratification of AML

Screening Patients for Efficient Clinical Trial Access (SPECTA)

IBCD 2016: Integrating assays into clinical trials

Innovative imaging techinques to visualise drug targets

Design and value of immunohistochemical assays

Making sense of genetic associations with childhood leukaemia risk

Development of a novel CD19 CAR with improved functionality

Targeted therapies in melanoma

Treatment of cutaneous T cell lymphoma

Skin cancer lesions arising in uncommon regions

Targetted medicine to reduce melanoma mutational burden

VISMO trial to treat basal cell carcinoma